Artificial intelligence (AI) is an emerging field which could make an intelligent healthcare
model a reality and has been garnering traction in the field of medicine, with promising …

Background/aims To improve the accuracy of pterygium screening and detection through
smartphones, we established a fusion training model by blending a large number of slit …

Pterygium, an ocular surface disorder, manifests as a wing-shaped extension from the
corneoscleral limbus onto the cornea, impacting vision and causing inflammation. With a …

Purpose Pterygium is a vision-threatening conjunctival fibrovascular degenerated disease
with a high global prevalence up to 12%, while no absolute pharmacotherapy has been …

Background/Aim: In the literature, the studies about the role of matrix metalloproteinase-2
(MMP-2) in pterygium diagnosis are mainly based on its protein expression. The role of …

To explore the correlation between tear LT-a, pterygium status, and dry eye indicators. We
established a diagnostic model to evaluate active pterygium. A retrospective study was …

Purpose: Low doses of systemic doxycycline (LD-SD) inhibit angiogenesis and the
expression of matrix metalloproteases, which are determinants of pterygium progression …

Objective To estimate the pterygium ocular surface state, and compare with healthy eyes
and dry eyes. To investigate the inflammation due to pterygia growth by tear Lymphotoxin …

Purpose To evaluate the effects of different pterygium surgery techniques on ocular surface
(OS) in different follow-up periods. Methods PubMed, Cochrane Library, Web of Science …

Purpose To evaluate the safety and efficacy of CBT-001, a multitarget tyrosine kinase
inhibitor eyedrop, for pterygia. Design Phase II clinical trial. Stage 1 was a single center …